| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PBB.2005.02.015 |
| P698 | PubMed publication ID | 15925401 |
| P2093 | author name string | Jonathon C Arnold | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocannabinoids | Q10483908 |
| P304 | page(s) | 396-406 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | The role of endocannabinoid transmission in cocaine addiction | |
| P478 | volume | 81 |
| Q36741898 | A neuropeptide-centric view of psychostimulant addiction |
| Q30429221 | ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure |
| Q47225379 | Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by nicotine |
| Q48145676 | Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence |
| Q100696968 | Beta-caryophyllene inhibits cocaine self-administration by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder |
| Q48569177 | Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. |
| Q33980198 | Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future |
| Q37322610 | Cannabinoid receptor 1 gene association with nicotine dependence |
| Q36342981 | Cannabinoid receptor 1-expressing neurons in the nucleus accumbens |
| Q48109648 | Cocaine self-administration differentially modulates the expression of endogenous cannabinoid system-related proteins in the hippocampus of Lewis vs. Fischer 344 rats |
| Q37554546 | Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice |
| Q38325368 | Common single nucleotide variants underlying drug addiction: more than a decade of research. |
| Q46866063 | Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant |
| Q37709569 | Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. |
| Q46160324 | Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice |
| Q48428879 | Effects of endocannabinoid neurotransmission modulators on brain stimulation reward |
| Q46726987 | Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy |
| Q49852274 | Fatty acid binding protein deletion prevents stress-induced preference for cocaine and dampens stress-induced corticosterone levels. |
| Q46652152 | Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice |
| Q37183687 | Hypothesis-driven medication discovery for the treatment of psychostimulant addiction |
| Q37526843 | Interaction between orexins and the mesolimbic system for overriding satiety |
| Q33889830 | Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample |
| Q33844393 | Methanandamide blocks amphetamine-induced behavioral sensitization in rats |
| Q27014154 | Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction |
| Q38278954 | Neuroinflammation as a possible link between cannabinoids and addiction. |
| Q28252765 | New treatments for cocaine dependence: a focused review |
| Q37304747 | Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence |
| Q34605939 | Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. |
| Q81099416 | Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats |
| Q35468865 | Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects |
| Q48610624 | Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior. |
| Q36960174 | Targeted modulators of the endogenous cannabinoid system: future medications to treat addiction disorders and obesity |
| Q37936694 | The genetic basis of the endocannabinoid system and drug addiction in humans. |
| Q34700186 | The role of acetylcholine in cocaine addiction. |
Search more.